Old Web
English
Sign In
Acemap
>
authorDetail
>
Liangwei Wang
Liangwei Wang
MedImmune
Asthma
Medicine
Physical therapy
Placebo
Clinical endpoint
3
Papers
416
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Tezepelumab demonstrates clinically meaningful improvements in asthma control (ACQ-6) in patients with uncontrolled asthma: results from a phase 2b clinical trial
2018
The Journal of Allergy and Clinical Immunology
Jonathan Corren
Jane R. Parnes
Liangwei Wang
May Mo
Stephanie L. Roseti
Janet M. Griffiths
Sean O'Quinn
René van der Merwe
Show All
Source
Cite
Save
Citations (4)
Tezepelumab in Adults with Uncontrolled Asthma
2017
The New England Journal of Medicine
Jonathan Corren
Jane R. Parnes
Liangwei Wang
May Mo
Stephanie L. Roseti
Janet M. Griffiths
René van der Merwe
Show All
Source
Cite
Save
Citations (412)
Late Breaking Abstract - Efficacy and safety of tezepelumab in adults with severe asthma: A randomized phase 2 study
2017
European Respiratory Journal
Stephanie L. Roseti
Jonathan Corren
Jane R. Parnes
May Mo
Janet M. Griffiths
Liangwei Wang
René van der Merwe
Show All
Source
Cite
Save
Citations (0)
1